A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
- Status
- RECRUITING
- Phase
- N/A
A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Galcanezumab in the Prevention of Chronic Migraine
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE1
Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3113593 in Participants With Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3154207 on Sleep in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of LY3200327 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE4
A Study of U-500 Insulin (LY041001) in Participants With Type 2 Diabetes
- Status
- TERMINATED
- Phase
- PHASE1
A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2